• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属蛋白酶抑制剂、γ-分泌酶抑制剂、蛋白激酶 C 抑制剂和 Rho 激酶抑制剂均可抑制野生型腺病毒的复制。

Inhibitors of metalloprotease, γ-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication.

机构信息

Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.

Summer Undergraduate Research Training Program, Baylor College of Medicine, Houston, Texas, United States of America.

出版信息

PLoS One. 2020 Jul 22;15(7):e0236175. doi: 10.1371/journal.pone.0236175. eCollection 2020.

DOI:10.1371/journal.pone.0236175
PMID:32697798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7375579/
Abstract

Adenoviruses cause upper respiratory infections, conjunctivitis, keratitis, and gastrointestinal illness. These can be fatal in immunocompromised individuals. Adenoviruses have also been engineered into viral vectors to deliver therapeutic genes or induce immunity as vaccine carriers. The success of ocular gene therapy is driven partly by the immunologic and biochemical influences of the intraocular environment. We have shown that versican and hyaluronan modulate adenoviral vector transgene expression through CD44 signaling. Herein we explored the role of these pathways on virus replication and viral protein expression of wild type adenovirus. We report that the addition of vitreous humor (which contains both versican and hyaluronan) increases viral hexon protein levels. Vitreous humor also increased wild type adenovirus DNA replication in vitro. Metalloproteinase and γ-secretase inhibitors, which inhibit CD44 proteolytic activation, blocked adenoviral replication in vitro. Similarly, protein kinase C and RhoA kinase inhibitors, both proteins associated with CD44 mediated pathways, also inhibited wild type adenoviral replication in vitro. Application of metalloproteinase and γ-secretase inhibitors to human conjunctival explants sharply decreased adenoviral vector gene expression. Our results demonstrate that pharmacologic delivery of these inhibitors is easily achievable. The inhibition of these enzymes should be explored as potential therapies of wild type adenoviral infections.

摘要

腺病毒可引起上呼吸道感染、结膜炎、角膜炎和胃肠道疾病。在免疫功能低下的个体中,这些疾病可能是致命的。腺病毒也被设计成病毒载体,以携带治疗基因或作为疫苗载体诱导免疫。眼基因治疗的成功部分是由于眼内环境的免疫学和生化影响。我们已经表明,软骨素聚糖和透明质酸通过 CD44 信号调节腺病毒载体转基因的表达。在此,我们探讨了这些途径对野生型腺病毒病毒复制和病毒蛋白表达的作用。我们报告说,玻璃体液(含有软骨素聚糖和透明质酸)的添加增加了病毒六邻体蛋白水平。玻璃体液还增加了野生型腺病毒在体外的 DNA 复制。金属蛋白酶和 γ-分泌酶抑制剂,可抑制 CD44 的蛋白水解激活,阻断了体外腺病毒的复制。同样,蛋白激酶 C 和 RhoA 激酶抑制剂,这两种与 CD44 介导的途径相关的蛋白,也抑制了野生型腺病毒在体外的复制。金属蛋白酶和 γ-分泌酶抑制剂在人结膜外植体上的应用显著降低了腺病毒载体基因的表达。我们的结果表明,这些抑制剂的药物输送是很容易实现的。抑制这些酶应该作为野生型腺病毒感染的潜在治疗方法进行探索。

相似文献

1
Inhibitors of metalloprotease, γ-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication.金属蛋白酶抑制剂、γ-分泌酶抑制剂、蛋白激酶 C 抑制剂和 Rho 激酶抑制剂均可抑制野生型腺病毒的复制。
PLoS One. 2020 Jul 22;15(7):e0236175. doi: 10.1371/journal.pone.0236175. eCollection 2020.
2
Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways.多功能蛋白聚糖G1结构域增强腺病毒介导的转基因表达,并且可被Janus激酶(JAK)/信号转导和转录激活因子(STAT)以及Src家族激酶途径的抑制剂所调节。
J Biol Chem. 2017 Sep 1;292(35):14381-14390. doi: 10.1074/jbc.M116.773549. Epub 2017 Jul 6.
3
The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression.CD44 细胞内结构域的释放调节腺病毒载体转导基因的表达。
J Biol Chem. 2012 Sep 21;287(39):32697-707. doi: 10.1074/jbc.M112.347369. Epub 2012 Aug 3.
4
Combinatorial targeting of 2 different steps in adenoviral DNA replication by herpes simplex virus thymidine kinase and artificial microRNA expression for the inhibition of virus multiplication in the presence of ganciclovir.单纯疱疹病毒胸苷激酶和人工 microRNA 表达联合靶向腺病毒 DNA 复制的 2 个不同步骤,在更昔洛韦存在的情况下抑制病毒增殖。
BMC Biotechnol. 2013 Jul 3;13:54. doi: 10.1186/1472-6750-13-54.
5
Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.一组药物对具有复制能力的腺病毒载体的单纯疱疹病毒1型胸苷激酶依赖性和非依赖性复制抑制作用的比较。
Cancer Gene Ther. 2003 Oct;10(10):791-802. doi: 10.1038/sj.cgt.7700638.
6
An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs.基于腺病毒载体的表达和递药系统,通过人工 microRNA 抑制野生型腺病毒复制。
Antiviral Res. 2013 Jan;97(1):10-23. doi: 10.1016/j.antiviral.2012.10.008. Epub 2012 Nov 2.
7
Construction of a novel oncolytic adenoviral vector and its biological characteristics.构建新型溶瘤腺病毒载体及其生物学特性。
Oncol Rep. 2013 Feb;29(2):798-804. doi: 10.3892/or.2012.2140. Epub 2012 Nov 15.
8
Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.在腺病毒感染的细胞中靶向表达单纯疱疹病毒胸苷激酶,在用更昔洛韦处理时可降低病毒滴度。
J Gene Med. 2012 Jan;14(1):3-19. doi: 10.1002/jgm.1638.
9
Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir.三管齐下抑制腺病毒复制:抗腺病毒 siRNA、可溶性腺病毒受体陷阱 sCAR-Fc 和更昔洛韦联合治疗。
Antiviral Res. 2015 Aug;120:72-8. doi: 10.1016/j.antiviral.2015.05.010. Epub 2015 May 27.
10
Longitudinal Monitoring of the Effects of Anti-Adenoviral Treatment Regimens in a Permissive In Vivo Model.在允许的体内模型中,对抗病毒治疗方案效果的纵向监测。
Viruses. 2024 Jul 26;16(8):1200. doi: 10.3390/v16081200.

引用本文的文献

1
Statin Therapy and the Risk of Viral Infection: A Retrospective Population-Based Cohort Study.他汀类药物治疗与病毒感染风险:一项基于人群的回顾性队列研究。
J Clin Med. 2022 Sep 24;11(19):5626. doi: 10.3390/jcm11195626.

本文引用的文献

1
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial.玻璃体内注射 Rho 激酶抑制剂(法舒地尔)联合贝伐单抗与贝伐单抗单药治疗糖尿病黄斑水肿的前瞻性随机临床试验。
Br J Ophthalmol. 2019 Jul;103(7):922-927. doi: 10.1136/bjophthalmol-2018-312244. Epub 2018 Aug 27.
2
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.治疗 RPE65 介导的遗传性视网膜营养不良患者的 voretigene neparvovec(AAV2-hRPE65v2)的疗效和安全性:一项随机、对照、开放标签、3 期临床试验。
Lancet. 2017 Aug 26;390(10097):849-860. doi: 10.1016/S0140-6736(17)31868-8. Epub 2017 Jul 14.
3
Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways.多功能蛋白聚糖G1结构域增强腺病毒介导的转基因表达,并且可被Janus激酶(JAK)/信号转导和转录激活因子(STAT)以及Src家族激酶途径的抑制剂所调节。
J Biol Chem. 2017 Sep 1;292(35):14381-14390. doi: 10.1074/jbc.M116.773549. Epub 2017 Jul 6.
4
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.布林西多福韦治疗儿童和成人异基因造血细胞移植受者无症状腺病毒血症:一项随机安慰剂对照II期试验
Biol Blood Marrow Transplant. 2017 Mar;23(3):512-521. doi: 10.1016/j.bbmt.2016.12.621. Epub 2017 Jan 5.
5
First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation.同种异体造血干细胞移植后符合良好生产规范(GMP)的多肽扩增腺病毒特异性 T 细胞的首例人体临床结果。
J Immunother. 2014 May;37(4):245-9. doi: 10.1097/CJI.0000000000000034.
6
Human adenovirus: Viral pathogen with increasing importance.人腺病毒:一种重要性日益增加的病毒病原体。
Eur J Microbiol Immunol (Bp). 2014 Mar;4(1):26-33. doi: 10.1556/EuJMI.4.2014.1.2. Epub 2014 Mar 14.
7
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.腺病毒载体用于基因治疗、疫苗接种和癌症基因治疗。
Curr Gene Ther. 2013 Dec;13(6):421-33. doi: 10.2174/1566523213666131125095046.
8
The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies.口服蛋白激酶 Cβ抑制剂罗格列酮在两项 3 期研究中对视力丧失的影响。
Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1750-7. doi: 10.1167/iovs.12-11055.
9
The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression.CD44 细胞内结构域的释放调节腺病毒载体转导基因的表达。
J Biol Chem. 2012 Sep 21;287(39):32697-707. doi: 10.1074/jbc.M112.347369. Epub 2012 Aug 3.
10
Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element.鉴定 CD44 胞质结构域(CD44-ICD)的功能:通过新型启动子反应元件调节基质金属蛋白酶 9(MMP-9)转录。
J Biol Chem. 2012 Jun 1;287(23):18995-9007. doi: 10.1074/jbc.M111.318774. Epub 2012 Mar 20.